Evidence map›Paper›PMID 39065176›Full record

ArticleMicroorganisms2024

Genomic Characterization of a Clinical NDM-1-Producing

Amanda Yaeko Yamada, Andreia Rodrigues de Souza, Amanda Maria de Jesus Bertani, Karoline Rodrigues Campos, Claudio Tavares Sacchi, Denise Brandão de Assis, Enéas de Carvalho, Elizabeth Harummyy Takagi, Marcos Paulo Vieira Cunha, Monique Ribeiro Tiba-Casas and 1 more

Abstract read
In one paragraph

Article in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Genomic characterisation and antimicrobial resistance ofFrontiers in cellular and infection microbiology · 2026
    Article
  4. Genome assembly ofFrontiers in microbiology · 2025
    Article
  5. Clonal dissemination of carbapenem-resistant ST477Frontiers in cellular and infection microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Amanda Yaeko YamadaInstituto Adolfo Lutz, São Paulo 01246-000, Brazil.
Andreia Rodrigues de SouzaInstituto Adolfo Lutz, São Paulo 01246-000, Brazil.
Amanda Maria de Jesus BertaniInstituto Adolfo Lutz, São Paulo 01246-000, Brazil.ORCID 0000-0003-2849-6653
Karoline Rodrigues CamposInstituto Adolfo Lutz, São Paulo 01246-000, Brazil.ORCID 0000-0002-5461-1937
Claudio Tavares SacchiInstituto Adolfo Lutz, São Paulo 01246-000, Brazil.
Denise Brandão de AssisDivisão de Infecção Hospitalar, Centro de Vigilância Epidemiológica, São Paulo 01246-000, Brazil.ORCID 0000-0002-5200-4121
Enéas de CarvalhoInstituto Butantan, São Paulo 05503-900, Brazil.
Elizabeth Harummyy TakagiInstituto Adolfo Lutz, São Paulo 01246-000, Brazil.
Marcos Paulo Vieira CunhaFaculdade de Medicina, Universidade de São Paulo, São Paulo 01246-000, Brazil.ORCID 0000-0002-8545-1518
Monique Ribeiro Tiba-CasasInstituto Adolfo Lutz, São Paulo 01246-000, Brazil.ORCID 0000-0001-7538-2582
Carlos Henrique CamargoInstituto Adolfo Lutz, São Paulo 01246-000, Brazil.

Funding

Brazilian Ministry of Health 444395/2023-7Conselho Nacional de Desenvolvimento Científico e Tecnológico 302543/2021-0, 402158/2021-0; 444395/2023-7Fundação de Amparo à Pesquisa do Estado de São Paulo 2022/11794-7; 2020/06157-2; 2018/21192-9; 2017/50333-7
6 · The paper itself

Abstract

Public health faces daily challenges due to increasing reports of pathogenic microorganisms with new antimicrobial resistance.

Indexed as

carbapenem-resistanceconjugationgenetic characterizationIncFIB plasmidwhole genome sequencing

Identifiers

PMID39065176
PMCPMC11278599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.